(Press-News.org) DETROIT - Innovative angles of attack in research that focus on how the human brain protects and repairs itself will help develop treatments for one of the most common, costly, deadly and scientifically frustrating medical conditions worldwide: traumatic brain injury.
In an extensive opinion piece recently published online on Expert Opinion on Investigational Drugs, Henry Ford Hospital researcher Ye Xiong, M.D., Ph.D., makes the case for pioneering work underway in Detroit and elsewhere seeking to understand and repair brain function at the molecular level.
"To date, all attempts at treating traumatic brain injury with experimental drugs have failed once testing moved from animal studies to clinical trials in humans," Dr. Xiong explains. "Although this is disappointing, we believe innovations now at the preclinical stage hold great promise for a deeper understanding of traumatic brain injury and how to treat it."
Also known as TBI, traumatic brain injury most commonly results from a sudden, violent blow to the head, in some cases driving broken bone into the brain, or from a bullet or other object piercing the skull and entering the brain.
This trauma sets off a complex "cascade" of reactions in the brain that can impair thinking and reasoning, behavior and movement.
Each year, at least 10 million TBIs that are serious enough to result in hospitalization or death occur around the world.
Most attempts at treatment have targeted the physical damage with drugs aimed at protecting neurons - the cells that carry messages from the brain to the rest of the body - from further damage. But while such attempts have shown promise in animal studies, they've all failed to help human patients.
Over the past three decades, more than 30 such clinical trials have ended in failure.
More recently, evidence has been amassed by researchers showing that the human brain has "a significant, albeit limited" ability to repair itself both physically and functionally, including:
Angiogenesis - the creation of new blood vessels.
Neurogenesis - the formation of new nerve cells.
Oligodendrogenesis - the development of several types of cells including those that make up the myelin sheath, a protective coating on parts of nerves.
Axonal sprouting - the process of in which undamaged axons, threadlike parts of nerve cells that carry signals to other cells, grow new nerve endings to relink damaged neurons.
The new approach to TBI therapy described by Dr. Xiong aims at enhancing these restorative, or "neuroplastic," processes as they work together to improve neurological recovery.
"Significant advances in the understanding of the mechanisms underlying TBI's behavioral, cognitive or psychiatric effects have been made, and the use of cell-based and pharmacological interventions to improve symptoms, function and outcome is still under development," Dr. Xiong explains.
Among interventional drugs now in early clinical trials are:
Glibenclamide. Already best known for treatment of type 2 diabetes, it has recently been found to significantly reduce brain swelling and bleeding after ischemic stroke, suggesting potential use for treating TBI.
Minocycline. Derived from the antibiotic tetracycline, it has been shown in different dosages to provide both short-term and long-term benefits in treating closed head injuries in mice.
Statins. Widely used to reduce cholesterol levels, studies at Henry Ford Hospital have demonstrated that these drugs restore cognitive function after TBI in rats.
Other promising investigational biologics and drugs that are now in promising preclinical development at Henry Ford include thymosin beta 4, exosomes recombinant human tissue plasminogen activator and microRNAs.
"Although it is still important to further investigate neuroprotective treatments for TBI, these novel, neurorestorative or neuroplastic approaches will facilitate development of treatments for TBI with the ultimate goal of reducing brain injury, promoting brain repair and remodeling, and eventually improving functional recovery and quality of life," Dr. Xiong concludes.
INFORMATION:
A blood thinning agent is helping researchers at the University of East Anglia understand more about the body's natural barriers to HIV.
New research published today reveals how the protein langerin, which is present in genital mucous and acts as a natural HIV barrier during the first stages of contamination, interacts with the drug heparin.
The research team has been able to identify two different mechanisms for that interaction - involving different sites or 'faces' at the surface of the langerin protein.
Lead researcher Dr Jesus Angulo from UEA's school of Pharmacy ...
Lexington, MA (March 23, 2015) - Research results published in the Journal of Neurotrauma and conducted by the Walter Reed Army Institute of Research (WRAIR) as part of a collaboration with Concert Pharmaceuticals, Inc. showed that a novel deuterium-containing sigma-1 agonist invented at Concert, called C-10068, demonstrated anti-seizure and anti-inflammatory effects in a preclinical model of traumatic brain injury (TBI). C-10068, a novel metabolically-stabilized morphinan derivative, is based on a compound first identified at WRAIR in the 1990s as possessing anticonvulsant ...
Many smartphone users know that free apps sometimes share private information with third parties, but few, if any, are aware of how frequently this occurs. An experiment at Carnegie Mellon University shows that when people learn exactly how many times these apps share that information they rapidly act to limit further sharing.
In one phase of a study that evaluated the benefits of app permission managers - software that gives people control over what sensitive information their apps can access - 23 smartphone users received a daily message, or "privacy nudge," telling ...
March 23, 2015 - Patients with carpal tunnel syndrome are more than twice as likely to have migraine headaches, reports a study in Plastic and Reconstructive Surgery--Global Open®, the official open-access medical journal of the American Society of Plastic Surgeons (ASPS).
The association also runs in the other direction, with migraine patients having higher odds of carpal tunnel syndrome, according to research by Dr. Huay-Zong Law and colleagues of University of Texas Southwestern Medical Center at Dallas. The findings add a new piece of evidence in the ongoing debate ...
This news release is available in French. Raising the age of eligibility for the Old Age Security pension and the Guaranteed Income Supplement will increase inequalities between older people. "This change will force retired people into greater dependence on their private savings to support them as they get older. Research shows that greater privatisation of the retirement income system results in growing inequalities among the older population. When you raise the pension eligibility age, you are also opening the door to rising disparities" according to demographer Yves ...
Implementing a well-established business approach allowed physicians to shave hours off pediatric patient discharges without affecting readmission rates, according to researchers at Penn State Hershey Children's Hospital.
This approach could help hospitals around the country open up existing beds to more patients, and reduce emergency department crowding and lost referrals without investing significant capital.
Most hospitals have a fixed number of staffed beds available for patients. When hospitals are at or exceed capacity, admitted patients may be kept in the ED ...
An extensive study of global habitat fragmentation - the division of habitats into smaller and more isolated patches - points to major trouble for a number of the world's ecosystems and the plants and animals living in them.
The study shows that 70 percent of existing forest lands are within a half-mile of the forest edge, where encroaching urban, suburban or agricultural influences can cause any number of harmful effects - like the losses of plants and animals.
The study also tracks seven major experiments on five continents that examine habitat fragmentation ...
NAIROBI, KENYA (20 March 2015)--African cattle infected with a lethal parasite that kills one million cows per year are less likely to die when co-infected with the parasite's milder cousin, according to a new study published today in Science Advances. The findings suggest that "fighting fire with fire" is a strategy that might work against a range of parasitic diseases.
The immediate implications are for the battle in Africa against a tick-borne cattle-killing parasite, Theileria parva, which causes East Coast fever. The disease kills one cow every 30 seconds and claims ...
PHILADELPHIA- Penn Medicine researchers have discovered that hypermethylation - the epigenetic ability to turn down or turn off a bad gene implicated in 10 to 30 percent of patients with Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Degeneration (FTD) - serves as a protective barrier inhibiting the development of these diseases. Their work, published this month in Neurology, may suggest a neuroprotective target for drug discovery efforts.
"This is the first epigenetic modification of a gene that seems to be protective against neuronal disease," says lead author ...
Philadelphia, PA, March 20, 2015 - A new study provides the first evidence that the mediator complex subunit 15 (MED15) may play a crucial role in the pathophysiology of head and neck squamous cell carcinoma (HNSCC). MED15 overexpression was found to be associated with higher mortality rates in HNSCC patients with cancer recurrence, particularly in oral cavity/oropharyngeal tumors, according to the study published in The American Journal of Pathology. MED15 overexpression was also associated with heavy alcohol consumption, which is an HNSCC risk factor.
HNSCC is the sixth ...
